Ortin Global Ltd
NSE: ORTINGLOBE BSE: 539287Pharma
Ortin Global Ltd (ORTINGLOBE) is a Pharma company listed on NSE: ORTINGLOBE | BSE: 539287. With a market cap of ₹11.5 Cr and ROCE of 25.1%, ROE of 36.2%, it operates in the Indian Pharma sector.
₹14.1
52W: ₹10.3 — ₹19.9
PE 0 · Book ₹1.6 · +781% vs bookMarket Cap₹11.5 Cr
Stock P/E—Price to Earnings
ROCE25.1%Return on Capital
ROE36.2%Return on Equity
Div. Yield0%Face Value ₹10
Strengths
- +Company has reduced debt.
Weaknesses
- −Stock is trading at 9.54 times its book value
- −Company has low interest coverage ratio.
- −The company has delivered a poor sales growth of -72.0% over past five years.
- −Promoter holding is low: 1.23%
- −Company has a low return on equity of -35.8% over last 3 years.
- −Contingent liabilities of Rs.24.3 Cr.
- −Company might be capitalizing the interest cost
- −Company has high debtors of 279 days.
- −Promoter holding has decreased over last 3 years: -20.3%
- −Working capital days have increased from 613 days to 1,524 days
Shareholding Pattern
Promoters1.23%
FIIs1.68%
DIIs0%
Public97.1%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% |
| FIIs | 6.25% | 6.25% | 6.25% | 6.53%▲0.3 | 6.53% | 1.68%▼4.9 | 1.68% | 1.68% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 92.53% | 92.52%▼0.0 | 92.52% | 92.24%▼0.3 | 92.24% | 97.08%▲4.8 | 97.09%▲0.0 | 97.1%▲0.0 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.27 | 0.14 | 0.3 | 0.21 | 0.05 | 0.03 | 0.09 | 0.08 | 0.01 | 0.01 |
| Expenses | 1.17 | 2.74 | 3.35 | 0.31 | 0.5 | 0.16 | 0.25 | 0.24 | 0.51 | 0.06 |
| Operating Profit | -0.9 | -2.6 | -3.05 | -0.1 | -0.45 | -0.13 | -0.16 | -0.16 | -0.5 | -0.05 |
| OPM % | -333.33% | -1857.14% | -1016.67% | -47.62% | -900% | -433.33% | -177.78% | -200% | -5000% | -500% |
| Net Profit | -1.12 | -2.79 | -4.14 | -0.1 | -0.47 | -0.11 | -0.16 | -0.18 | -0.5 | -0.05 |
| EPS ₹ | -1.38 | -3.43 | -5.09 | -0.12 | -0.58 | -0.14 | -0.2 | -0.22 | -0.61 | -0.06 |
AI Insights
Revenue Trend
TTM revenue at ₹0.19Cr, down 44.1% YoY. OPM at -457.89%.
Debt Position
Borrowings at ₹0.93Cr. Debt-to-equity ratio: N/Ax. High leverage — monitor closely.
Institutional Flow
DIIs: 0% (+0.00pp change). FIIs: 1.68% (+1.68pp change). Promoters hold 1.23%.
Margin & Efficiency
ROCE declining from 13.08% (Mar 2014) to -25.11% (Mar 2025). Working capital days: 1524.41.
Recent Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 6 May - Ortin Global confirms it is not a Large Corporate for FY 2026-27.
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 30 Apr - Ortin Global says it is not a Large Corporate for FY2025-26; debt borrowing nil.
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 11 Apr - Filed Regulation 74(5) compliance certificate for quarter ended 31 March 2026.
- Closure of Trading Window 30 Mar
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse